Fig. 2From: Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trialChange in the water balance from baseline at each time point in the placebo, 7.5 mg and 15 mg tolvaptan groups. Data are expressed as the mean ± SDBack to article page